Bionano_RGB.png
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
07 nov. 2024 16h01 HE | Bionano Genomics
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
Bionano_RGB.png
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
31 oct. 2024 16h30 HE | Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under...
Bionano_RGB.png
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024
31 oct. 2024 08h10 HE | Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it adjourned its reconvened Special Meeting of Stockholders originally held on October 2, 2024...
Bionano_RGB.png
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
31 oct. 2024 08h00 HE | Bionano Genomics
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the...
Bionano_RGB.png
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
24 oct. 2024 08h00 HE | Bionano Genomics
Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methodsThe release of compelling data in MM underscores the potential...
Bionano_RGB.png
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10 oct. 2024 08h00 HE | Bionano Genomics
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects...
Bionano_RGB.png
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
03 oct. 2024 08h00 HE | Bionano Genomics
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on October 2, 2024 (the “Special...
Bionano_RGB.png
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
04 sept. 2024 08h00 HE | Bionano Genomics
Bionano to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Bionano_RGB.png
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
07 août 2024 16h01 HE | Bionano Genomics
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
Bionano_RGB.png
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
01 août 2024 08h00 HE | Bionano Genomics
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a...